Ocular Therapeutix
OCUL
#4846
Rank
A$2.67 B
Marketcap
A$12.29
Share price
1.92%
Change (1 day)
17.73%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2025 (TTM): -A$0.41 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are A$51.95 Million. a decrease over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.39 Billion37.43%
2024 -A$0.29 Billion139.68%
2023 -A$0.12 Billion13.65%
2022 -A$0.11 Billion984.05%
2021 -A$9.49 Million-95.79%
2020 -A$0.23 Billion80.19%
2019 -A$0.13 Billion44.01%
2018 -A$86.83 Million-5.38%
2017 -A$91.76 Million41.79%
2016 -A$64.72 Million12.47%
2015 -A$57.54 Million38.75%
2014 -A$41.48 Million115.12%
2013 -A$19.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-A$16.23 Million-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
A$18.84 M-104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-A$0.24 Billion-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.36 B-194.42%๐Ÿ‡บ๐Ÿ‡ธ USA